ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
OncoC4, Inc.
Genmab
Exscientia AI Limited
Seagen Inc.
SystImmune Inc.
Guardant Health, Inc.
Numab Therapeutics AG
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Celldex Therapeutics
Numab Therapeutics AG
Tempus AI
Pfizer
Taproot Health
23andMe, Inc.
Mundipharma Research Limited
Hoffmann-La Roche
ADC Therapeutics S.A.
Celldex Therapeutics
Gilead Sciences
pharmaand GmbH
Celldex Therapeutics
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Celgene
Critical Outcome Technologies Inc.
Sanofi
Santa Maria Biotherapeutics
INSYS Therapeutics Inc